Evommune, Inc. (EVMN)
NYSE: EVMN · Pharmaceutical Preparations · Palo Alto, CA · filing with the SEC since 2025
Who runs Evommune, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Pena Luis C.
President & CEO. First filing Nov 2025, latest Oct 15, 2026, 2 filings in all.
Officers reporting now
6
of 21 people with a filing in the last fifteen months
Directors reporting now
15
21 people on the record since 2025
Officerssales are open-market, Oct 15, 2025 to Oct 15, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Pena Luis C. | President & CEO | Nov 2025 | Oct 15, 2026 | 2 · $600,000 |
| Carver Kyle | Chief Financial Officer | Nov 2025 | Jul 10, 2026 | 1 · $400,000 |
| Drew Janice Suzann | Chief of Dev. Operations | Nov 2025 | Jun 24, 2026 | 1 · $500,000 |
| Patel Jeegar Pravinkumar | Chief Scientific Officer | Nov 2025 | Jun 24, 2026 | 2 · $400,000 |
| Moss Gregory S. | Chief Business & Legal Officer | Nov 2025 | Jun 1, 2026 | 1 · $300,000 |
| Bauer Eugene | Chief Medical Officer | Nov 2025 | Apr 17, 2026 | none |
Directorssales are open-market, Oct 15, 2025 to Oct 15, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kirsch Arthur S | director | Nov 2025 | Jul 8, 2026 | none |
| Cohen David E | director | Nov 2025 | Jun 3, 2026 | 2 · $100,000 |
| Mcgraw Benjamin F III | director | Nov 2025 | Jun 3, 2026 | none |
| Lsp 7 Cooperative Ua | director | Nov 2025 | Feb 19, 2026 | none |
| Verduyn-Van Weegen Felice Isabel | director | Nov 2025 | Feb 18, 2026 | none |
| Kolchinsky Peter | director | Nov 2025 | Feb 17, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Nov 2025 | Feb 17, 2026 | none |
| Ra Capital Management, L.P. | director | Nov 2025 | Feb 17, 2026 | none |
| Ra Capital Nexus Fund III, L.P. | director | Nov 2025 | Feb 17, 2026 | none |
| Shah Rajeev M. | director | Nov 2025 | Feb 17, 2026 | none |
| Hopfner Robert Lorne | director | Nov 2025 | Dec 22, 2025 | none |
| Pivotal Bioventure Partners Fund I G.P., L.P. | director | Nov 2025 | Nov 12, 2025 | none |
| Pivotal Bioventure Partners Fund I U.G.P. Ltd | director | Nov 2025 | Nov 12, 2025 | none |
| Pivotal Bioventure Partners Fund I, L.P. | director | Nov 2025 | Nov 12, 2025 | none |
| Dirocco Derek | director | Nov 2025 | Nov 5, 2025 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.